Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor - Grossmann, RE; Geisen, U; Schwender, S (Thromb Haemost, 2000)
et al.